Latest GM & Biosafety Resources

Cliquez ici pour le français The ACB shares this research paper with you, of the wave of ‘Trojan horse’ second-generation genetic engineering strategies targeted at, inter alia, malaria in Africa, at a time when the COVID-19 crisis is fracturing the myth that global health expertise is the domain of North America and Europe. Global health […]

The African Centre for Biodiversity (ACB) has produced a briefing paper in regard to a new and controversial genetic engineering (GE) technology to produce gene drive organisms (GDOs). These GDOs have been specifically designed to spread an engineered, ‘modified’ genetic trait such as sterility, with the potential to eradicate entire wildlife populations and even species. […]

Press Release from the African Centre for Biodiversity AU’s premature and misguided endorsement of controversial, unproven gene drive mosquitos for malaria ‘eradication’ in Africa Johannesburg, Monday, 5 November 2018 The African Union (AU) is paving the way for the entry of the latest and most controversial form of genetic engineering, gene drive technologies. In July […]

A heated public debate on genetically modified organisms (GMOs) ensued during a seminar organised by MVIWATA – a network of smallholder farmers – in Morogoro, Tanzania. The meeting took place on 12 May 2018 and was attended by more than a hundred people, including parliamentarians and high-level government officials. The event, which was intended only […]

The news that the Swaziland Environmental Authority (SEA) had authorised the importation and commercial release of Bt cotton seeds came as a huge shock to the African Centre for Biodiversity (ACB). It meant that ACB had to reconsider its earlier acceptance of an invitation by SEA to attend a National Biosafety Indaba on 22 May […]

The Water Efficient Maize for Africa (WEMA) project promises to develop drought tolerance in maize for the benefit of small holder farmers, but is really a project designed to facilitate the spread of hybrid and genetically modified (GM) maize varieties on the continent. WEMA involves five African countries: Kenya, Mozambique, South Africa, Tanzania and Uganda. […]

This paper examines the application of the Bt cotton field trials currently underway in Swaziland. This is situated within the broader wave of GM application and trials across the continent, along with the weakening of national biosafety regulations, as part of the GM push across Africa. This paper is based on research on the Swaziland […]

The African Centre for Biodiversity (ACB) has today released a new report titled, GM and seed industry eye Africa’s lucrative cowpea seed markets: The political economy of cowpea in Nigeria, Burkina Faso, Ghana and Malawi. The report shows a strong interest by the seed industry in commercialising cowpea seed production and distribution in West Africa, […]

The Africa Centre for Biosafety (ACB) has dismissed the findings of the biotechnology industry’s flagship annual report, published by the GM industry funded ‘NGO’, the International Service for the Acquisition of Agri-biotech Applications (ISAAA), as mischievous and erroneous. According to the report, South Africa’s GM crop area increased by a record 26% or 600,000 hectares […]

An urgent appeal has been made to the African Union (AU) to discuss a ban on the cultivation, import and export of genetically modified (GM) crops in Africa at the next AU summit, to be held in January 2013. An African Civil Society Statement, signed by over 400 African organisations representing small-scale farmers, faith-based organisations, […]

“The African Centre for Biosafety (ACB) has been handed a document of the Common Market for Eastern and Southern Africa (COMESA) titled ‘Draft Policy Statements and Guidelines for commercial plantings of GMOs, Trade in GMOs and Emergency Food aid with GMO content.” The Policy intends to undermine and displace more than a decade’s worth of […]

Monsanto has made an application to the South African GMO authorities for permission to import Smartstax maize, one of the most controversial and risky GMOs ever produced for commercial use. The ACB recently published a report featuring Smartstax titled ‘The stacked gene revolution: A biosafety nightmare’. We pointed out that while the majority of commercially […]